Other Information
+Added: a) Information Required to be Reported on Form 8-K
+Added: (b) Material Changes to Nomination Procedures
+Added: (c) Director and Officer Trading Plans and Arrangements
+Added: On June 6, 2023 , Randal W.
+Added: Scott, Ph.D .
+Added: , a member of our Board of Directors , adopted a trading plan for the sale of a maximum of 16,000 shares of our common stock (the “June 6 Plan”).
+Added: The June 6 Plan is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) and is expected to remain in effect until the earlier of (1) September 30, 2024 and (2) the date on which an aggregate of 16,000 shares of our common stock have been sold under such plan.
+Added: On June 15, 2023 , Frank McCormick , Ph.D., a member of our Board of Directors , adopted a trading plan for the sale of a maximum of 200,000 shares of our common stock (the “June 15 Plan”).
+Added: The June 15 Plan is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) and is expected to remain in effect until the earlier of (1) September 19, 2024 and (2) the date on which an aggregate of 200,000 shares of our common stock have been sold under such plan.
Exhibit Title
20 unchanged sentences
January 29, 2021
−Removed: Consulting Agreement between Frank McCormick and the Registrant, effective as of January 1, 2021.
−Removed: February 23, 2023
−Removed: Amendment No.
−Removed: 1 to Consulting Agreement between Frank McCormick and the Registrant, effective as of March 3, 2022.
−Removed: February 23, 2023
−Removed: Amendment No.
−Removed: 2 to Consulting Agreement between Frank McCormick and the Registrant, effective as of March 3, 2023.
−Removed: February 23, 2023
BridgeBio Pharma, Inc.
Amended and Restated 2019 Inducement Equity Plan, effective February 10, 2023.
+Added: Equity Distribution Agreement dated May 4, 2023, by and among the Company and Goldman Sachs & Co.
+Added: LLC and SVB Securities LLC.
+Added: Form of Restricted Stock Unit Award Agreement under BridgeBio Pharma, Inc.
+Added: Amended and Restated 2019 Inducement Equity Plan (2023 Form).
Filed herewith
+Added: Form of Restricted Stock Award Agreement under BridgeBio Pharma, Inc.
+Added: Amended and Restated 2019 Inducement Equity Plan (2023 Form).
+Added: Filed herewith
+Added: Form of Non-Qualified Stock Option Agreement under BridgeBio Pharma, Inc.
+Added: Amended and Restated 2019 Inducement Equity Plan (2023 Form).
+Added: Filed herewith
+Added: Form of Restricted Stock Unit Award Agreement under 2021 Amended and Restated BridgeBio Pharma, Inc.
+Added: Stock Option and Incentive Plan (2023 Form).
+Added: Filed herewith
+Added: Form of Restricted Stock Award Agreement under 2021 Amended and Restated BridgeBio Pharma, Inc.
+Added: Stock Option and Incentive Plan (2023 Form).
+Added: Filed herewith
+Added: Form of Non-Qualified Stock Option Agreement under 2021 Amended and Restated BridgeBio Pharma, Inc.
+Added: Stock Option and Incentive Plan (2023 Form).
+Added: Filed herewith
+Added: Form of Non-Qualified Stock Option Agreement under 2021 Amended and Restated BridgeBio Pharma, Inc.
+Added: Stock Option and Incentive Plan for Board of Directors (2023 Form).
+Added: Filed herewith
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 .
23 unchanged sentences
# Indicates a management contract or any compensatory plan, contract or arrangement.
−Removed: Certain confidential portions (indicated by brackets and asterisks) have been omitted from this exhibit in accordance with the rules of the Securities and Exchange Commission because such information (i) is not material and (ii) is the type that the Registrant treats as private or confidential.
* This certification will not be deemed “filed”
3 unchanged sentences
BridgeBio Pharma, Inc.
+Added: August 3, 2023
/s/ Neil Kumar
2 unchanged sentences
(Principal Executive Officer)
+Added: August 3, 2023
/s/ Brian Stephenson
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.